AMAG Pharmaceuticals
AMAG
AMAG was delisted on the 13th of November, 2020.
107 hedge funds and large institutions have $518M invested in AMAG Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 9 closing their positions.
140% more call options, than puts
Call options by funds: $1.92M | Put options by funds: $801K
111% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 9
18% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 33
15% more capital invested
Capital invested by funds: $449M → $518M (+$69.3M)
10% more funds holding
Funds holding: 97 → 107 (+10)
2.3% more ownership
Funds ownership: 95.59% → 97.89% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$15.3M |
| 2 |
JGC
J. Goldman & Co
New York
|
+$3.68M |
| 3 |
Morgan Stanley
New York
|
+$3.52M |
| 4 |
Millennium Management
New York
|
+$3.09M |
| 5 |
JP Morgan Chase
New York
|
+$2.46M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$14.2M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.4M |
| 3 |
CM
Castleark Management
Chicago,
Illinois
|
-$7.06M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$3.99M |
| 5 |
First Manhattan
New York
|
-$2.82M |
AMAG Hedge Fund Activity: Q4 2013 in Review
107 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in AMAG Pharmaceuticals (AMAG) for Q4 2013, worth a combined $518M — up 15% from $449M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new AMAG positions and 9 closed out — a net gain of 10 holders — while 39 added to existing stakes and 33 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $15.3M. The largest seller was Fidelity Investments, cutting an estimated $14.2M.
- 107 institutional investors held AMAG Pharmaceuticals (AMAG) as of Q4 2013, up from 97 in Q3 2013.
- Funds reported $518M of AMAG Pharmaceuticals stock for Q4 2013, up 15% quarter-over-quarter.
- 19 funds opened new AMAG Pharmaceuticals positions in Q4 2013 and 9 closed out, a net change of +10 holders.
- The largest AMAG Pharmaceuticals buyer in Q4 2013 was BlackRock Institutional Trust, an estimated $15.3M added.
- The largest AMAG Pharmaceuticals seller in Q4 2013 was Fidelity Investments, an estimated $14.2M sold.
Based on aggregated 13F filings for Q4 2013.